Center for Scientific Review; Notice of Closed Meetings, 6645-6647 [E9-2600]
Download as PDF
Federal Register / Vol. 74, No. 26 / Tuesday, February 10, 2009 / Notices
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation on or before February
9, 2009. Time allotted for each
presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by February 10, 2009.
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Christine
Walsh or Denise Royster at least 7 days
in advance of the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/oc/advisory/
default.htm for procedures on public
conduct during advisory committee
meetings.
FDA regrets that it was unable to
publish this notice 15 days prior to the
February 18 and 19, 2009, Vaccines and
Related Biological Products Advisory
Committee meeting. Because the agency
believes there is some urgency to bring
these issues to public discussion and
qualified members of the Vaccines and
Related Biological Products Advisory
Committee were available at this time,
the Commissioner of Food and Drugs
concluded that it was in the public
interest to hold this meeting even if
there was not sufficient time for the
customary 15-day public notice.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
erowe on PROD1PC63 with NOTICES
Dated: January 30, 2009.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E9–2726 Filed 2–5–09; 4:15 pm]
BILLING CODE 4160–01–S
VerDate Nov<24>2008
14:17 Feb 09, 2009
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel,
February 12, 2009, 3 p.m. to February
12, 2009, 5 p.m., National Institutes of
Health, 6701 Rockledge Drive, Bethesda,
MD 20892 which was published in the
Federal Register on January 30, 2009, 74
FR 5661.
The meeting will be held February 23,
2009, from 4 p.m. to 5:30 p.m. The
meeting location remains the same.
The meeting is closed to the public.
Dated: February 2, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–2599 Filed 2–9–09; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended.The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflicts: Cognition and Hearing.
Date: February 25–26, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Christine L. Melchior,
PhD, Scientific Review Officer, Center for
Scientific, Review National Institutes of
Health, 6701 Rockledge Drive, Room 5176,
MSC 7844, Bethesda, MD 20892, (301) 435–
1713, melchioc@csr.nih.gov.
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
6645
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Ion
Channels.
Date: February 26, 2009.
Time: 10 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Mary Custer, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4148,
MSC 7850, Bethesda, MD 20892–7850, (301)
435–1164, custerm@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflicts: Synaptic Plasticity.
Date: February 26, 2009.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Daniel R. Kenshalo, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5176,
MSC 7844, Bethesda, MD 20892, 301–435–
1255, kenshalod@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Small
Business: Medical Imaging
Date: March 3–4, 2009.
Time: 8 a.m.to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bahia Resort Hotel, 998 W. Mission
Bay Drive, San Diego, CA 92109.
Contact Person: Leonid V. Tsap, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5128,
MSC 7854, Bethesda, MD 20892, (301) 435–
2507, tsapl@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Technological Innovations for
Interdisciplinary Research on Behavioral
Sciences.
Date: March 6, 2009.
Time: 2 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Mayflower Hotel, 1127
Connecticut Avenue, NW., Washington, DC
20036.
Contact Person: Biao Tian, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 3089B, MSC 7848, Bethesda,
E:\FR\FM\10FEN1.SGM
10FEN1
erowe on PROD1PC63 with NOTICES
6646
Federal Register / Vol. 74, No. 26 / Tuesday, February 10, 2009 / Notices
MD 20892, (301) 402–4411,
tianbi@csr.nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group, AIDS
Molecular and Cellular Biology Study
Section.
Date: March 9, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bahia Resort Hotel, 998 W. Mission
Bay Drive, San Diego, CA 92109.
Contact Person: Kenneth A. Roebuck, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5214,
MSC 7852, Bethesda, MD 20892, (301) 435–
1166, roebuckk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business: Respiratory Sciences.
Date: March 9, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Ghenima Dirami, PhD,
Scientific Review Officer, Center for
Scientific, Review National Institutes of
Health, 6701 Rockledge Drive, Room 4112,
MSC 7814, Bethesda, MD 20892, 301–594–
1321, diramig@csr.nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group
Behavioral and Social Consequences of HIV/
AIDS Study Section.
Date: March 9–10, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bahia Resort Hotel, 998 W. Mission
Bay Drive, San Diego, CA 92109.
Contact Person: Mark P. Rubert, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–435–
1775, rubertm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR–08–
105: Optimizing Technologies for the
Preservation of Fertility (R21s).
Date: March 9, 2009.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Stuart B. Moss, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6170,
MSC 7892, Bethesda, MD 20892, 301–435–
1044, mossstua@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Conflicts: Schizophrenia, Cognitive
Impairment and Intervention.
Date: March 10, 2009.
Time: 7 a.m. to 9 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Nov<24>2008
14:17 Feb 09, 2009
Jkt 217001
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Melissa Gerald, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3172,
MSC 7848, Bethesda, MD 20892, (301) 435–
0692, geraldmel@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Diabetes,
Obesity and Metabolic Diseases.
Date: March 10–11, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Nancy Sheard, SCD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6046–E,
MSC 7892, Bethesda, MD 20892, 301–435–
1154, sheardn@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Cellular and
Molecular Immunology Special Emphasis
Panel.
Date: March 10–11, 2009.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Patrick K. Lai, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2215,
MSC 7812, Bethesda, MD 20892, 301–435–
1052, laip@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Metabolic
Endocrinology 2.
Date: March 10–11, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Reed A. Graves, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6166,
MSC 7892, Bethesda, MD 20892, (301) 402–
6297, gravesr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Topics in
Bacterial Pathogenesis.
Date: March 12–13, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, VA 22314.
Contact Person: Rolf Menzel, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3196,
MSC 7808, Bethesda, MD 20892, 301–435–
0952, menzelro@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, F05
Fellowship—Cell Biology.
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
Date: March 12–13, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Georgetown Suites, 1000 29th Street,
NW., Washington, DC 20007.
Contact Person: Alessandra M. Bini, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5142,
MSC 7840, Bethesda, MD 20892, 301–435–
1024, binia@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Brain
Disorders and Related Neuroscience.
Date: March 12–13, 2009.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: One Washington Circle Hotel, One
Washington Circle, Washington, DC 20037.
Contact Person: George Ann McKie, DVM,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1124,
MSC 7846, Bethesda, MD 20892, 301–435–
1049, mckiegeo@csr.nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group,
NeuroAIDS and other End-Organ Diseases
Study Section.
Date: March 12, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street, NW., Washington, DC 20037.
Contact Person: Ranga V. Srinivas, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5216,
MSC 7852, Bethesda, MD 20892, (301) 435–
1167, srinivar@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business: Non-HIV Anti-Infective
Therapeutics.
Date: March 12–13, 2009.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Pier 5 Hotel, 711 Eastern Avenue,
Baltimore, MD 21202.
Contact Person: Rossana Berti, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3191,
MSC 7846, Bethesda, MD 20892, 301–402–
6411, bertiros@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Health
Literacy.
Date: March 12–13, 2009.
Time: 6 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Delfina Santa Monica, 530
West Pico Boulevard, Santa Monica, CA
90405.
Contact Person: Karen Lechter, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3128,
MSC 7759, Bethesda, MD 20892, 301–496–
0726, lechterk@csr.nih.gov.
E:\FR\FM\10FEN1.SGM
10FEN1
Federal Register / Vol. 74, No. 26 / Tuesday, February 10, 2009 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Cell Biology
SBIR/STTR.
Date: March 13, 2009.
Time: 8 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street, NW., Washington, DC 20037.
Contact Person: Alexandra M. Ainsztein,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5144,
MSC 7840, Bethesda, MD 20892, 301–451–
3848, ainsztea@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 2, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–2600 Filed 2–9–09; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of Research on Women’s
Health; Notice of Meeting; Moving Into
the Future—New Dimensions and
Strategies for Women’s Health
Research for the National Institutes of
Health
erowe on PROD1PC63 with NOTICES
Notice is hereby given that the Office
of Research on Women’s Health
(ORWH), Office of the Director, National
Institutes of Health, Department of
Health and Human Services, in
collaboration with the Center for
Women’s Infectious Disease Research,
Washington University School of
Medicine, will convene a public hearing
and scientific workshop on March 4–6,
2009, at Washington University, Edward
P. Newman Education Center, St. Louis,
Missouri.
Purpose of the Meeting
With rapid advances in science and
wider global understanding of women’s
health and sex/gender contributions to
well-being and disease, the purpose of
the meeting is to ensure that NIH
continues to support cutting edge
women’s health research that is based
upon the most advanced techniques and
methodologies. The conference format
will promote an interactive discussion
involving leading scientists, advocacy
groups, public policy experts, health
care providers, and the general public.
The St. Louis conference is the first in
a series that will be convened
VerDate Nov<24>2008
14:17 Feb 09, 2009
Jkt 217001
throughout the Nation to assist the
ORWH and the NIH to move into the
next decade of women’s health research.
As science and technology advance
and fields such as computational
biology demonstrate the power of
interdisciplinary research, it remains
critical for sex and gender factors to be
integrated into broad experimental
methodologies and scientific
approaches, such as genomics and the
Human Microbiome Project, to
maximize the value of these
comprehensive and powerful
approaches. Biomedical and behavioral
research are also necessary to
understand how cultural, ethnic, and
racial differences influence the cause,
diagnosis, progression, treatment, and
outcome of disease among different
populations, including women of
diverse geographic locations and
socioeconomic backgrounds.
Furthermore, health disparities among
diverse populations of women remain a
critical area in need of continued focus
and attention.
The ORWH challenges all conference
attendees to assist it and the NIH in
defining the women’s health research
agenda of the future and to think
beyond traditional women’s health
issues. The attendees need to identify
creative strategies that are best poised
for advancement, address innovative
ways to approach persistent issues of
health and disease, and explore new
scientific concepts and investigative
approaches. The attendees need to pay
attention to new areas of science
application, new technologies, or
continuing basic science investigations.
The attendees should also consider
clinical questions that are not currently
the focus of research priorities to ensure
that women’s health research is
optimally served and that the ORWH
can continue to provide leadership for
the benefit of women’s health,
nationally and internationally.
Conference Format
The Conference will consist of public
testimony followed by scientific panels
and six concurrent workshops.
Specifically, on March 4, individuals
representing the full spectrum of
organizations interested in biomedical
and behavioral research on women’s
health issues will have an opportunity
to provide public testimony from 2–6
p.m. On March 5, the intersection of
health care, public policy, and
biomedical research will be addressed
in a keynote speech designed to
stimulate discussion by subsequent
panels. The panels will focus on
emerging issues and trends in health
care that will be facing the Nation and
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
6647
on research paradigms of the future. The
six concurrent afternoon sessions will
focus on a range of research areas,
including metagenomics/microbiome,
chronic pain, urogenital disorders, the
brain and neuropsychiatric disorders,
urogenital infection, and obesity and
eating disorders. On March 6, the
morning session will be devoted to
reports from the workshop co-chairs on
the deliberations of the workshops.
Throughout the sessions, conference
attendees will be encouraged to assist
the ORWH and NIH in shaping the
future of women’s health research and,
by extension, informing health care
policy. The conference will adjourn at 1
p.m. on March 6.
Public Testimony
The ORWH invites individuals
representing organizations with an
interest in research areas related to
women’s health to provide written and
oral testimony on these topics and/or on
issues related to women in biomedical
careers. Due to time constraints, only
one representative from an organization
or professional specialty group will
present oral testimony, with
presentations limited to 5–7 minutes.
Similarly, individuals not representing
an organized entity but a personal point
of view will have the same time
constraint. A letter of intent to present
such testimony should be sent
electronically to https://
www.orwhmeetings.com/newdirections/
or by mail to Ms. Jory Barone,
Educational Services, Inc., 4350 EastWest Highway, Suite 1100, Bethesda,
MD 20814, joryb@esi-dc.com. The date
of receipt of the communication will
establish the order of presentations at
the March meeting.
Testimony should include a brief
description of the organization; is
limited to no more than 10 pages,
double spaced, 12 point font size; and
should be forwarded to the Web site
listed above no later than February 20,
2009.
Individuals and organizations wishing
to provide written statements only
should send two (2) copies of their
statements, electronically or by mail, to
the above Web site or address by
February 20, 2009. All written
testimony will be made available to the
conferees prior to the March 4 meeting
date. Logistics questions related to the
March conference should be addressed
to Ms. Jory Barone at ESI, while
program-specific questions should be
addressed to Dr. Jennifer Stine Elam at
Washington University, 314–747–0729,
elam@wustl.edu.
This conference is the first of four
regional public hearings and scientific
E:\FR\FM\10FEN1.SGM
10FEN1
Agencies
[Federal Register Volume 74, Number 26 (Tuesday, February 10, 2009)]
[Notices]
[Pages 6645-6647]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-2600]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended.The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflicts: Cognition and Hearing.
Date: February 25-26, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Christine L. Melchior, PhD, Scientific Review
Officer, Center for Scientific, Review National Institutes of
Health, 6701 Rockledge Drive, Room 5176, MSC 7844, Bethesda, MD
20892, (301) 435-1713, melchioc@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Ion Channels.
Date: February 26, 2009.
Time: 10 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Telephone Conference Call)
Contact Person: Mary Custer, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4148, MSC 7850, Bethesda, MD 20892-7850, (301)
435-1164, custerm@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflicts: Synaptic Plasticity.
Date: February 26, 2009.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Telephone Conference Call)
Contact Person: Daniel R. Kenshalo, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5176, MSC 7844, Bethesda, MD
20892, 301-435-1255, kenshalod@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Small Business: Medical Imaging
Date: March 3-4, 2009.
Time: 8 a.m.to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bahia Resort Hotel, 998 W. Mission Bay Drive, San Diego,
CA 92109.
Contact Person: Leonid V. Tsap, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5128, MSC 7854, Bethesda, MD 20892, (301) 435-
2507, tsapl@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Technological Innovations for Interdisciplinary Research on
Behavioral Sciences.
Date: March 6, 2009.
Time: 2 p.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Renaissance Mayflower Hotel, 1127 Connecticut Avenue,
NW., Washington, DC 20036.
Contact Person: Biao Tian, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3089B, MSC 7848, Bethesda,
[[Page 6646]]
MD 20892, (301) 402-4411, tianbi@csr.nih.gov.
Name of Committee: AIDS and Related Research Integrated Review
Group, AIDS Molecular and Cellular Biology Study Section.
Date: March 9, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bahia Resort Hotel, 998 W. Mission Bay Drive, San Diego,
CA 92109.
Contact Person: Kenneth A. Roebuck, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5214, MSC 7852, Bethesda, MD
20892, (301) 435-1166, roebuckk@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Small Business: Respiratory Sciences.
Date: March 9, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Ghenima Dirami, PhD, Scientific Review Officer,
Center for Scientific, Review National Institutes of Health, 6701
Rockledge Drive, Room 4112, MSC 7814, Bethesda, MD 20892, 301-594-
1321, diramig@csr.nih.gov.
Name of Committee: AIDS and Related Research Integrated Review
Group Behavioral and Social Consequences of HIV/AIDS Study Section.
Date: March 9-10, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bahia Resort Hotel, 998 W. Mission Bay Drive, San Diego,
CA 92109.
Contact Person: Mark P. Rubert, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 20892, 301-435-
1775, rubertm@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, PAR-08-105: Optimizing Technologies for the Preservation of
Fertility (R21s).
Date: March 9, 2009.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Stuart B. Moss, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6170, MSC 7892, Bethesda, MD 20892, 301-435-
1044, mossstua@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Member Conflicts: Schizophrenia, Cognitive Impairment and
Intervention.
Date: March 10, 2009.
Time: 7 a.m. to 9 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting)
Contact Person: Melissa Gerald, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3172, MSC 7848, Bethesda, MD 20892, (301) 435-
0692, geraldmel@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Diabetes, Obesity and Metabolic Diseases.
Date: March 10-11, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting)
Contact Person: Nancy Sheard, SCD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6046-E, MSC 7892, Bethesda, MD 20892, 301-435-
1154, sheardn@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Cellular and Molecular Immunology Special Emphasis Panel.
Date: March 10-11, 2009.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting)
Contact Person: Patrick K. Lai, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 2215, MSC 7812, Bethesda, MD 20892, 301-435-
1052, laip@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Metabolic Endocrinology 2.
Date: March 10-11, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting)
Contact Person: Reed A. Graves, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6166, MSC 7892, Bethesda, MD 20892, (301) 402-
6297, gravesr@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Topics in Bacterial Pathogenesis.
Date: March 12-13, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria,
VA 22314.
Contact Person: Rolf Menzel, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3196, MSC 7808, Bethesda, MD 20892, 301-435-
0952, menzelro@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, F05 Fellowship--Cell Biology.
Date: March 12-13, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Georgetown Suites, 1000 29th Street, NW., Washington, DC
20007.
Contact Person: Alessandra M. Bini, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5142, MSC 7840, Bethesda, MD
20892, 301-435-1024, binia@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Brain Disorders and Related Neuroscience.
Date: March 12-13, 2009.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: One Washington Circle Hotel, One Washington Circle,
Washington, DC 20037.
Contact Person: George Ann McKie, DVM, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1124, MSC 7846, Bethesda, MD
20892, 301-435-1049, mckiegeo@csr.nih.gov.
Name of Committee: AIDS and Related Research Integrated Review
Group, NeuroAIDS and other End-Organ Diseases Study Section.
Date: March 12, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: The Fairmont Washington, DC, 2401 M Street, NW.,
Washington, DC 20037.
Contact Person: Ranga V. Srinivas, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5216, MSC 7852, Bethesda, MD
20892, (301) 435-1167, srinivar@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Small Business: Non-HIV Anti-Infective Therapeutics.
Date: March 12-13, 2009.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Pier 5 Hotel, 711 Eastern Avenue, Baltimore, MD 21202.
Contact Person: Rossana Berti, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3191, MSC 7846, Bethesda, MD 20892, 301-402-
6411, bertiros@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Health Literacy.
Date: March 12-13, 2009.
Time: 6 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Delfina Santa Monica, 530 West Pico Boulevard,
Santa Monica, CA 90405.
Contact Person: Karen Lechter, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3128, MSC 7759, Bethesda, MD 20892, 301-496-
0726, lechterk@csr.nih.gov.
[[Page 6647]]
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Cell Biology SBIR/STTR.
Date: March 13, 2009.
Time: 8 a.m. to 7 p.m.
Agenda: To review and evaluate grant applications.
Place: The Fairmont Washington, DC, 2401 M Street, NW.,
Washington, DC 20037.
Contact Person: Alexandra M. Ainsztein, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5144, MSC 7840, Bethesda, MD
20892, 301-451-3848, ainsztea@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: February 2, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-2600 Filed 2-9-09; 8:45 am]
BILLING CODE 4140-01-M